Virus dynamics and drug therapy

被引:480
作者
Bonhoeffer, S
May, RM
Shaw, GM
Nowak, MA
机构
[1] UNIV OXFORD, DEPT ZOOL, OXFORD OX1 3PS, ENGLAND
[2] UNIV ALABAMA, DIV HEMATOL ONCOL, BIRMINGHAM, AL 35294 USA
基金
英国惠康基金;
关键词
D O I
10.1073/pnas.94.13.6971
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The recent development of potent antiviral drugs not only has raised hopes for effective treatment of infections with HIV or the hepatitis B virus, but also has led to important quantitative insights into viral dynamics in vivo, Interpretation of the experimental data depends upon mathematical models that describe the nonlinear interaction between virus and host cell populations. Here we discuss the emerging understanding of virus population dynamics, the role of the immune system in limiting virus abundance, the dynamics of viral drug resistance, and the question of whether virus infection can be eliminated from individual patients by drug treatment.
引用
收藏
页码:6971 / 6976
页数:6
相关论文
共 61 条
  • [31] MULTIPLE MUTATIONS IN HIV-1 REVERSE-TRANSCRIPTASE CONFER HIGH-LEVEL RESISTANCE TO ZIDOVUDINE (AZT)
    LARDER, BA
    KEMP, SD
    [J]. SCIENCE, 1989, 246 (4934) : 1155 - 1158
  • [32] Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
    Ling, R
    Mutimer, D
    Ahmed, N
    Boxall, EH
    Elias, E
    Dusheiko, GM
    Harrison, TJ
    [J]. HEPATOLOGY, 1996, 24 (03) : 711 - 713
  • [33] HIV-1 RNA SERUM-LOAD AND RESISTANT VIRAL GENOTYPES DURING EARLY ZIDOVUDINE THERAPY
    LOVEDAY, C
    KAYE, S
    TENANTFLOWERS, M
    SEMPLE, M
    AYLIFFE, U
    WELLER, IVD
    TEDDER, RS
    [J]. LANCET, 1995, 345 (8953) : 820 - 824
  • [34] LOWER IN-VIVO MUTATION-RATE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAN THAT PREDICTED FROM THE FIDELITY OF PURIFIED REVERSE-TRANSCRIPTASE
    MANSKY, LM
    TEMIN, HM
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (08) : 5087 - 5094
  • [35] SELECTION AND ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-I VARIANTS WITH INCREASED RESISTANCE TO ABT-538, A NOVEL PROTEASE INHIBITOR
    MARKOWITZ, M
    MO, HM
    KEMPF, DJ
    NORBECK, DW
    BHAT, TN
    ERICKSON, JW
    HO, DD
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (02) : 701 - 706
  • [36] POPULATION-DYNAMICS OF HIV WITHIN AN INDIVIDUAL AFTER TREATMENT WITH ZIDOVUDINE
    MCLEAN, AR
    EMERY, VC
    WEBSTER, A
    GRIFFITHS, PD
    [J]. AIDS, 1991, 5 (05) : 485 - 489
  • [37] COMPETITION BETWEEN ZIDOVUDINE-SENSITIVE AND ZIDOVUDINE-RESISTANT STRAINS OF HIV
    MCLEAN, AR
    NOWAK, MA
    [J]. AIDS, 1992, 6 (01) : 71 - 79
  • [38] T-cell homeostasis, competition, and drift: AIDS as HIV-accelerated senescence of the immune repertoire
    Mittler, JE
    Levin, BR
    Antia, R
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 12 (03): : 233 - 248
  • [39] ANTIGENIC OSCILLATIONS AND SHIFTING IMMUNODOMINANCE IN HIV-1 INFECTIONS
    NOWAK, MA
    MAY, RM
    PHILLIPS, RE
    ROWLANDJONES, S
    LALLOO, DG
    MCADAM, S
    KLENERMAN, P
    KOPPE, B
    SIGMUND, K
    BANGHAM, CRM
    MCMICHAEL, AJ
    [J]. NATURE, 1995, 375 (6532) : 606 - 611
  • [40] ANTIGENIC DIVERSITY THRESHOLDS AND THE DEVELOPMENT OF AIDS
    NOWAK, MA
    ANDERSON, RM
    MCLEAN, AR
    WOLFS, TFW
    GOUDSMIT, J
    MAY, RM
    [J]. SCIENCE, 1991, 254 (5034) : 963 - 969